ReviewHead and neck pathology2014
Malignant odontogenic tumors: an update on selected tumors.
Review in Head and neck pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Malignant Odontogenic Tumours: A Systematic Review of Cases Reported in Literature.Frontiers in oral health · 2021Pooled it
- Early Detection of Jaw Malignancies: Insights From Three Clinical Case Reports for Dental Professionals.Cureus · 2025Article
- Investigating the Role of DNA Ploidy and Proliferation Index in Distinguishing Ameloblastoma from Ameloblastic Carcinoma.Head and neck pathology · 2025Article
- Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma.Head and neck pathology · 2024Article
- A Current Review of Machine Learning and Deep Learning Models in Oral Cancer Diagnosis: Recent Technologies, Open Challenges, and Future Research Directions.Diagnostics (Basel, Switzerland) · 2023Review
- A novel parotid carcinoma with a prominent ghost cell population: a masquerading tumor or "salivary ghost cell carcinoma"?Medical molecular morphology · 2022Article
- Odontogenic carcinosarcoma - A rare case report with review of literature.Journal of oral and maxillofacial pathology : JOMFP · 2022Article
- Dentinogenic Ghost Cell Tumor in a Sumatran Rhinoceros.Animals : an open access journal from MDPI · 2021Article
- Clinico-pathological study of malignant odontogenic tumours from a national referral centre.BMC oral health · 2021Article
- Analyses of odontogenic tumours: the most recent classification proposed by the World Health Organization (2017).Medicina oral, patologia oral y cirugia bucal · 2020Review
- Sclerosing Odontogenic Carcinoma with Local Recurrence: Case Report and Review of Literature.Head and neck pathology · 2019Review
- Clear Cell Odontogenic Carcinoma: Occurrence of EWSR1-CREB1 as Alternative Fusion Gene to EWSR1-ATF1.Head and neck pathology · 2019Article
- A multi-centre evaluation of malignant odontogenic tumours in Nigeria.The Pan African medical journal · 2019Article
- Controversies in Odontogenic Tumours: Review.Sultan Qaboos University medical journal · 2017Review
- Odontogenic tumors: where are we in 2017 ?Journal of Istanbul University Faculty of Dentistry · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is an update on selected odontogenic malignancies. The article deals with aspects of recognized odontogenic carcinomas, odontogenic sarcoma and a yet unrecognized entity, sclerosing odontogenic carcinoma. Odontogenic malignancies are exceedingly rare, complicating a thorough understanding of the biologic behavior, reproducible standardized diagnostic criteria, appropriate classification and clinical management. Without the knowledge of the tumor's biologic behavior, adequate clinical management is difficult and patient outcomes uncertain. The histopathologic features are emphasized as well as the more recent biomarker findings. These recent advances may facilitate further understanding of this group of malignancies and provide useful stratification to guide patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.